Multicenter Clinical Evaluation of the (1->3) -D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in Humans
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Measurement of (1-->3)-beta-D-Glucan (BG) has emerged as an adjunct diagnostic strategy for invasive fungal infections (IFI). METHODS: Subjects at 6 clinical sites in the United States were enrolled as either fungal infection-negative subjects (n = 170) or subjects with proven or probable IFI according to European Organization for the Research and Treatment of Cancer/Mycoses Study Group criteria (n = 163). A central laboratory and 4 sites performed assays. A single sample was obtained per patient and was evaluated using an assay to detect serum BG derived from fungal cell walls (range, 0 to > 7000 pg/mL). RESULTS: At a cutoff of 60 pg/mL, the sensitivity and specificity of the assay were 69.9% and 87.1%, respectively, with a positive predictive value (PPV) of 83.8% and a negative predictive value (NPV) of 75.1%. At a cutoff value of 80 pg/mL, the sensitivity and specificity were 64.4% and 92.4%, respectively, with a PPV of 89% and an NPV of 73%. Of the 107 patients with proven candidiasis, 81.3% had positive results at a cutoff value of 60 pg/mL, and 77.6% had positive results at a cutoff value of 80 pg/mL. Of the 10 patients with aspergillosis, 80% had positive results at cutoff values of 60 and 80 pg/mL. The 3 subjects diagnosed with Fusarium species had positive results at a cutoff value of 60 pg/mL. Patients infected with Mucor or Rhizopus species (both of which lack BG) had negative results at both cutoff values, and of the 12 patients with Cryptococcus infection, 3 had positive results at a cutoff value of 60 pg/mL, and 2 had positive results at a cutoff value of 80 pg/mL. Of the subjects with proven positive results who were receiving antifungal therapy (n = 118), 72.9% had results positive for BG at a cutoff value of 60 pg/mL, and 69.5% had results positive for BG at a cutoff value of 80 pg/mL. The interlaboratory sample test r2 was 0.93. CONCLUSION: Reproducible assay results with high specificity and high PPV in a multicenter setting demonstrate that use of an assay to detect serum BG derived from fungal cell walls is a useful diagnostic adjunct for IFI.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sensitivity and specificity have been estimated to be 69.9 and 87.1%, respectively [47], as there are a high number of false positive results.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [47]
In the citing paper
“(1 ?3)-b-D-glucan is a component of the cell wall of many fungi and has been proposed as a non-specific marker for invasive fungal infections.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [47]
In the citing paper
“b-1, 3-D-Glucan detection has also been evaluated in critically ill patients, with sensitivity and specificity for diagnosis of IC estimated to be 69.9% and 87.1%, respectively.63”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [63]
Citations
Cites
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331 · cited 3×
“Subjects. Subjects without IFI and subjects with proven or probable IFI (determined according to the European Organization for the Research and Treatment of Cancer/Mycoses Study Group [EORTC/MSG] criteria [ 15 ]) from 6 clinical sites in the United States consented to participate in this study, and a single blood samp…”
MethodSelf-citation(2012) · Hepatogastroenterology · doi:10.5754/hge11801 · Cited by 802
Odabasi, Z., Mattiuzzi, G., Estey, E., Kantarjian, H., Saeki, F., Ridge, R. J., Ketchum, P. A., Finkelman, M. A., Rex, J. H., & Ostrosky-Zeichner, L. (2004) · Clinical Infectious Diseases · doi:10.1086/421944 · Cited by 642 · cited 4×
“The reactivity of the Fungitell assay with Pachyman standard is lower than that of the Fungitec-G assay [9].”
BackgroundMethodSelf-citationObayashi, T., Kawai, T., Yoshida, M., Mori, T., Goto, H., Yasuoka, A., Shimada, K., Iwasaki, H., Teshima, H., Kohno, S., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91152-9 · Cited by 530
Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States
Ostrosky-Zeichner, L., Rex, J. H., Pappas, P. G., Hamill, R. J., Larsen, R. A., Horowitz, H. W., Powderly, W. G., Hyslop, N., Kauffman, C. A., Cleary, J., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3149-3154.2003 · Cited by 498 · cited 1×
“parapsilosis [19].”
Self-citationThe use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis
Horvath, J. A., & Dummer, S. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89455-7 · Cited by 323 · cited 1×
“of cases of invasive aspergillosis [4].”
The New Fungal Opportunists Are Coming
Perfect, J. R., & Schell, W. A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_2.s112 · Cited by 224 · cited 1×
“critical care [1].”
Miyazaki, T., Kohno, S., Mitsutake, K., Maesaki, S., Tanaka, K., Ishikawa, N., & Hara, K. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.12.3115-3118.1995 · Cited by 204
Digby, J., Kalbfleisch, J. H., Glenn, A., Larsen, A. R., Browder, W., & Williams, D. L. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.5.882-885.2003 · Cited by 153 · cited 2×
“[18] observed low specificity for fungal infections in a study involving 46 subjects in intensive care units.”
BackgroundMolecular mechanism of hemolymph clotting system in Limulus
Iwanaga, S., Miyata, T., Tokunaga, F., & Muta, T. (1992) · Thrombosis Research · doi:10.1016/0049-3848(92)90124-s · Cited by 133 · cited 1×
“BG produced by fungi [6] is detected by a glucan assay on the basis of its recognition by the innate immune system of horseshoe crabs, specifically Tachypleus tridentatus and Limulus polyphemus [7].”
Background
Research works printed but not linked: 1
- Nakao, 1997, Hepato-gastroenterology, 44, 1413
Cited by
Items 601–667 of 667
Non–Culture-Based Methods for the Diagnosis of Invasive Candidiasis
Mayr, A., & Lass‐Flörl, C. (2011) · Current Fungal Infection Reports · doi:10.1007/s12281-011-0060-z · Cited by 1
Can fungal biomarkers be used to improve antifungal therapy in the intensive care unit?
Ostrosky-Zeichner, L. L. (2009) · Current Fungal Infection Reports · doi:10.1007/s12281-009-0019-5
Self-citationMedical Mycology for the Hospital Epidemiologist
Barron, M. A. (2012) · Current Fungal Infection Reports · doi:10.1007/s12281-011-0077-3
“Several studies have evaluated the use of PCR in the diagnosis of IFIs [26–31].”
InfluentialBlennow, O. (2014) · Figshare
Diagnostik von Aspergillusinfektionen in der Hämatologie und Onkologie
Aigner, M., Mutschlechner, W., & Lass‐Flörl, C. (2012) · Mycoses · doi:10.1111/j.1439-0507.2012.02177.x
Clinical Microbiology Reviews(CMR)
Coburn, B. A., Sekirov, I., Finlay, B. B., Finlay, Dykes, C., & Demeter, L. M. (2007)
in High-Risk Oncology Patients
Cohen, N., Dubnow, S., & Seo, S. K. (2010)
Cinel, İ., Dellinger, R. P., Eggimann, P., Strunk, T., Richmond, P., Simmer, K. N., Currie, A., Levy, O., Burgner, D. P., van Dissel, J. T., et al. (2007)
Invasive Candidiasis in Management of Infections in Cancer Patients
Bassetti, M., Mikulska, M., Gea‐Banacloche, J., & Viscoli, C. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-644-3_24
Wiederhold, N. P., & Sutton, D. A. (2016) · Fungal biology · doi:10.1007/978-3-319-29137-6_18
Shikanai‐Yasuda, M. A., & Paulo, S. (2015)
Fan, X. D., Yang, J. D., Chen, X., Sun, Y., & Xu, X. (2014)
1,3-β-D-Glucan in Patients Receiving Intravenous Amoxicillin-Clavulanic Acid
Moritz, M. L., & Ayus, J. C. (2006)
Immunomodulators: What is the Evidence for Use in Mycoses?
Alspaugh, J. A. (2009) · CRC Press eBooks · doi:10.3109/9780849387869-9
Infectious Issues After Pancreas Transplant
Desai, A., & Boruchoff, S. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-20789-6_8-2
Infectious Diseases: Deep Fungal Infections
Motaparthi, K. (2016) · Springer eBooks · doi:10.1007/978-3-319-43630-2_17
Detection and Management of Fungal Respiratory Infection by Using Molecular Markers
Ali, M. (2017) · Fungal biology · doi:10.1007/978-3-319-34106-4_10 · Cited by 1
Update: invasive Pilzinfektionen Diagnose und Therapie in der operativen Intensivmedizin
Anaesthesiologie, K. F., Heidelberg, U., & Briegel, J. (2010)
Candidemia: New Directions for Management and Treatment
Theppote, A. (2017) · Springer eBooks · doi:10.1007/978-3-319-64774-6_3
Britto, J. (2018) · The University of Louisville Journal of Respiratory Infections · doi:10.18297/jri/vol2/iss1/9
“Although not an antigen test, detection of (1-3)-Beta-D-Glucan in serum has been shown to be a useful adjunct for diagnosis of invasive fungal infections, especially candidiasis, aspergillosis, and histoplasmosis [21-23].”
BackgroundBritto, J., & St. Elizabeth Physicians, I. D. (2018) · The University of Louisville Journal of Respiratory Infections · doi:10.18297/jri/vol2/iss2/8/
“Although not an antigen test, detection of (1→3)-β-D-glucan (BG) in serum has been shown to be a useful adjunct for diagnosis of invasive fungal infections, especially candidiasis, aspergillosis, pneumocystosis, and histoplasmosis [57-59].”
BackgroundRüping, M. J. G. T., Vehreschild, J. J., Ewig, S., & Cornely, O. A. (2009) · Wiley eBooks · doi:10.1002/9780470714171.ch6
Smith, P. B., & Steinbach, W. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00243-7
Masfufatun, Raharjo, L. H., Harsono, & Baktir, A. (2019) · Open Chemistry · doi:10.1515/chem-2019-0146 · Cited by 1
Smith, P. B., & Steinbach, W. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2702-9.00245-2 · Cited by 3
Chronic invasive candidiasis in murine CARD9-deficiency
Landekic, M. (2021) · eScholarship@McGill (McGill) · doi:10.82308/17175 · Cited by 1
副鼻腔真菌症から緩徐に進行する Garcin 症候群をきたした1症例
柳, 徳., & 雄太, 清. (2020) · 耳鼻咽喉科展望 · doi:10.11453/orltokyo.63.4_158
Gupta, V., & Goel, A. (2021) · Springer eBooks · doi:10.1007/978-981-16-5105-2_10
Yoshida, M. (2009) · Springer eBooks · doi:10.1007/978-90-481-2408-4_8
New Developments in Diagnostics and Management of Invasive Candidiasis
Krishnan, S., & Ostrosky-Zeichner, L. L. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch28 · Cited by 1
Self-citationInfectious Issues After Pancreas Transplant
Desai, A., & Boruchoff, S. E. (2019) · Organ and tissue transplantation · doi:10.1007/978-3-319-05257-1_2008
Patterson, T. F. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6640-7_14 · Cited by 1
Fungal Infections in Cancer Patients
Granwehr, B. P., Sipsas, N. V., & Kontoyiannis, D. P. (2019) · Springer eBooks · doi:10.1007/978-3-319-74698-2_121-1
Knapp, K. M., & Flynn, P. M. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-4044-6.50217-x
Preemptive Antifungal Therapy: Do Diagnostics Help?
Hanson, K. E. (2009) · CRC Press eBooks · doi:10.3109/9780849387869-7
Zhang, S. X., & Wiederhold, N. P. (2016) · ASM Press eBooks · doi:10.1128/9781555819040.ch15
Bishop, J. A., & Merz, W. G. (2008) · Wiley eBooks · doi:10.1128/9781555815455.ch11
Traboulsi, R. S. (2009) · CRC Press eBooks · doi:10.3109/9780849387869-18
Smith, P. B., & Steinbach, W. J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-7020-3468-8.50250-9 · Cited by 3
Procop, G. W., Hayden, R. T., & Roberts, G. D. (2008) · Wiley eBooks · doi:10.1128/9781555815455.ch10 · Cited by 1
ANOFEL, Botterel, F., Dardé, M., Debourgogne, A., Delhaès, L., Houzé, S., Morio, F., Kauffmann-Lacroix, C., & Roques, C. (2017) · Elsevier eBooks · doi:10.1016/b978-2-294-75363-3.00051-3
Infectious Issues After Pancreas Transplant
Desai, A., & Boruchoff, S. E. (2016) · Springer eBooks · doi:10.1007/978-3-319-20789-6_8-1
ANOFEL, Houzé, S., & Delhaès, L. (2022) · Elsevier eBooks · doi:10.1016/b978-2-294-77766-0.00052-2
Answer to January 2023 Photo Quiz
Rattin, J., Albarillo, F. S., Kanakis, C. E., Abdelsattar, Z. M., Syed, D., Harrington, A., & Ananthanarayanan, V. (2023) · Journal of Clinical Microbiology · doi:10.1128/jcm.00781-22
Fungal Endocarditis Secondary to Transdermal Fentanyl Patch
Casey, B., Bahekar, A., Patel, D. R., Walker, E., & Ilaiwy, A. (2023) · Cureus · doi:10.7759/cureus.38706
Tatara, A. M. (2023) · Springer eBooks · doi:10.1007/978-3-031-39474-4_5
Ali, S., Sadiq, Z., Sajjad, M. M., Ali, M. S., Raza, S. S., & Akhtar, A. (2024) · Pakistan Journal of Health Sciences · doi:10.54393/pjhs.v5i09.2224
Diagnostics of Candida and Candidiasis: Current Methods and Future Perspectives
Banik, S. (2024) · Springer eBooks · doi:10.1007/978-981-97-4909-6_1 · Cited by 2
Fusarium and Other Opportunistic Hyaline Fungi
Zhang, S. X., O'Donnell, K. L., Wiederhold, N. P., & Cañete-Gibas, C. F. (2023) · ClinMicroNow · doi:10.1002/9781683674849.mcm0124
Diagnostic Studies: Role of Biomarkers
White, P. L. (2024) · Springer eBooks · doi:10.1007/978-3-031-76524-7_6
Fusarium and Other Opportunistic Hyaline Fungi
Zhang, S. X., O'Donnell, K. L., Wiederhold, N. P., & Cañete-Gibas, C. F. (2023) · ClinMicroNow · doi:10.1002/9781683670438.mcm0124
Duong, R. T., Doyle, A. M., & Venkat, A. (2025) · American Journal of Ophthalmology Case Reports · doi:10.1016/j.ajoc.2025.102331
“12,13 Further efforts are warranted to better screen for the risk for deceased donor fungal infections which can lead to devasting consequences in recipients of their organs, especially if they go unrecognized initially.”
Benders, P. M. B., Schouten, J. A., Vena, A., Buil, J. B., Bronkhorst, E., & Bassetti, M. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-10644-9 · Cited by 2
Steinbach, W. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00215-6
Krysan, D. J., Wellington, M. A., & Steinbach, W. J. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00224-7
Opportunistic Infections in Hematopoietic Stem Cell Transplantation
Dara, J. S., & Dvorak, C. C. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-82763-8.00071-6
Introduction to Fungal Infections
Richa, R., Saxena, R. K., & Namrata (2025) · Fungal biology · doi:10.1007/978-3-032-06014-3_1
Rhino-orbital conidiobolomycosis in non-endemic Settings. A diagnostic and therapeutic challenge
Gueneau, R., Tanaka, L., Reimbold, P., Haroche, J., Nabet, C., & Jauréguiberry, S. (2025) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2025.102931
Hasan, A. (2025) · Springer eBooks · doi:10.1007/978-981-96-7810-5_43
Fatal Pulmonary Mucormycosis in a Renal Transplant Recipient: A Missed Opportunistic Infection
Correa, T., Braden, G. L., Greco, B., Brand, K., Obeidat, Y., & Khan, U. (2026) · Cureus · doi:10.7759/cureus.106886
“In a multicenter study evaluating the Fungitell assay (cutoff 80 pg/mL), the negative predictive value was 73%, and the positive predictive value was 89% [12].”
Kopczyk, M. K., Mulroney, K. T., Weaire‐Buchanan, G., Paton, T. F., Salisbury, E., Ho, W. S., Gardam, D. J., Higgins, A., Carson, C. F., Inglis, T. J. J., et al. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1813126
Miyazaki, A., Hamada, S., Okabayashi, H., Akaike, K., Masunaga, A., Okamoto, S., Tomita, Y., Ichiyasu, H., & Sakagami, T. (2026) · Journal of Fungi · doi:10.3390/jof12060427 · Cited by 1
Clinical Utility and Diagnostic Performance of (1→3)-β-D-Glucan in Invasive Mycoses
Tao, L., Zhang, S. X., Dufresne, P. J., & Misra, A. (2026) · Clinical Chemistry · doi:10.1093/clinchem/hvag108
Xiao, Y., Wu, S., Wu, C., Yuan, Y., Wang, Y., Liu, Z., Zhang, D., Gu, L., Chu, X., Song, G., et al. (2026) · Medical Mycology · doi:10.1093/mmy/myag062
Invasive fungal infections in critically ill patients
Meersseman, W. (2008)
Metadata
- Authors
- Ostrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R., Tamura, H., Finkelman, M. A., & Rex, J. H.
- Affiliations
- Duke University (US)
- University of Miami (US)
- University of Alabama at Birmingham (US)
- Seikagaku Corporation (Japan) (JP)
- University of Florida Health (US)
- College of Idaho (US)
- AstraZeneca (United Kingdom) (GB)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-01
- Volume
- 41
- Issue
- 5
- Pages
- 654-659
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2127508258
- Cited by
- 669
- References
- 26
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 12 · 2023: 14 · 2022: 7 · 2021: 15 · 2020: 16 · 2019: 25 · 2018: 25 · 2017: 21 · 2016: 38 · 2015: 29 · 2014: 50 · 2013: 42 · 2012: 39
- FWCI
- 29.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- β-1,3-glucan, invasive fungal infections, fungal infection diagnosis, candidiasis, aspergillosis, Fusarium, Mucor, Rhizopus, Cryptococcus, antifungal therapy, sensitivity and specificity, cut-off values, interlaboratory agreement, serum biomarkers, EORTC/MSG criteria
- MeSH terms
- Adult, Aged, Female, Humans, Male, Middle Aged, Mycoses, Proteoglycans, Sensitivity and Specificity, Reproducibility of Results, beta-Glucans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.